Susquehanna International Group’s Loxo Oncology, Inc LOXO Stock Holding History

Susquehanna International Group’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-48,300	Closed	-$6.76M	–	10498
2018 Q4	$6.76M	Sell	48,300 -35,600	-42%	-$5.4M	﹤0.01%	1957
2018 Q3	$14.3M	Sell	83,900 -39,900	-32%	-$6.71M	﹤0.01%	1601
2018 Q2	$21.5M	Buy	123,800 +4,100	+3%	+$616K	0.01%	1238
2018 Q1	$13.8M	Buy	119,700 +76,900	+180%	+$8.18M	﹤0.01%	1527
2017 Q4	$3.6M	Sell	42,800 -18,100	-30%	-$1.51M	﹤0.01%	2948
2017 Q3	$5.61M	Buy	60,900 +47,800	+365%	+$3.71M	﹤0.01%	2361
2017 Q2	$1.05M	Buy	+13,100	New	+$726K	﹤0.01%	5160

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Susquehanna International Group's LOXO Position: Q1 2019 in Review

Susquehanna International Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 4,201 shares — an estimated $588K sold.

Susquehanna International Group first reported a position in LOXO in Q3 2014 and held it in 4 quarters. The position peaked at $4.03M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Susquehanna International Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Susquehanna International Group sold 4,201 Loxo Oncology, Inc shares in Q1 2019, an estimated $588K.
Susquehanna International Group first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 4 quarters.
Susquehanna International Group's Loxo Oncology, Inc position peaked at $4.03M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Susquehanna International Group's 13F filing for Q1 2019, filed 15 May 2019.